2.4 Association between increased glycolysis with clinical response and survival rates in ALs Despite the strong evidence that glycolytic metabolism can promote chemoresistance in primary leukemic cells from non-responders and/or multiresistant cell lines, recent advances in metabolomics platforms have allowed further investigation into tumor metabolism at the systemic level in patients with acute leukemia (Kim et al., 2021), however, only a few studies have focused on the impact of glycolytic alterations on response to chemotherapy treatment, with mixed results
Accordingly, pharmacological inhibition of SLC7A11 or cysteine deprivation blocks GSH synthesis, leads to GSH depletion, and induces ferroptosis by disabling the antioxidant defense system 85,137
Mol Metab 2022;65:101590.ArticlePubMedPMC 80
Taking it first thing in the morning, about 1520 minutes before breakfast, allows the liposomes to move through the digestive tract without competing with food
Ethical and Legal Implications for Doctors and Patients The situation with BPC-157 raises difficult ethical questions in medicine
